Expression and clinicopathologic significance of CD44v6/CD24 in ovarian serous carcinomas

Chinese Journal of Pathology

Volumn 43, Issue 1, 2014, Pages 20-24

  Wang, Aichun ^a   Lu, Lijuan ^a   Wang, Yun ^a   Sun, Yunfei ^a   Zhang, Yan ^a   Guo, Chao ^a   Gu, Yiqun ^a   Liu, Aijun ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Antigens; CD24; CD44; Neoplastic stem cells; Ovarian neoplasms; Prognosis

Indexed keywords

CD24 ANTIGEN; CD44V6 ANTIGEN; HERMES ANTIGEN;

ADULT; AGE; AGED; ARTICLE; CANCER GRADING; CANCER STAGING; CYSTADENOCARCINOMA; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; METABOLISM; MIDDLE AGED; OVARY TUMOR; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; SURVIVAL RATE; TUMOR RECURRENCE; YOUNG ADULT;

ADULT; AGE FACTORS; AGED; ANTIGENS, CD24; ANTIGENS, CD44; CYSTADENOCARCINOMA, SEROUS; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; OVARIAN NEOPLASMS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SURVIVAL RATE; YOUNG ADULT;

EID: 84894228572     PISSN: 05295807     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0529-5807.2014.01.005     Document Type: Article

References (10)

1. Malpica A, Deavers MT, Lu K, et al Grading ovarian serous carcinoma using a two-tier system [J]. Am J Surg Pathol, 2004, 28(4): 496-504. (Pubitemid 38436523)
2. Shi J, Zhou Z, Di W., et al Correlation of CD44v6 expression with ovarian cancer progression and recurrence[J]. BMC Cancer, 2013, 13: 182.
3. Oktem G, Sanci M, Bilir A., et al Cancer stem cell and embryonic development-associated molecules contribute to prognostic significance in ovarian cancer [J]. Int J Gynecol Cancer, 2012, 22(1): 23-29.
4. Ikenaga N, Ohuchida K, Mizumoto K., et al Characterization of CD24 expression in intraductal papillary mucinous neoplasms and ductal carcinoma of the pancreas [J]. Hum Pathol, 2010, 41 (10): 1466-1474.
5. Lim SC, Oh SH The role of CD24 in various human epithelial neoplasias[J]. Pathol Res Pract, 2005, 201(7): 479486.
6. Liu M, Mor G, Cheng H., et al High frequency of putative ovarian cancer stem cells with CD44/CK19 coexpression is associated with decreased progression-free intervals in patients with recurrent epithelial ovarian cancer [J]. Reprod Sci, 2013, 20(5): 605-615.
7. Steffensen KD, Alvero AB, Yang Y, et al Prevalence of epithelial ovarian cancer stem cells correlates with recurrence in early-stage ovarian cancer[J]. J Oncol, 2011, 2011: 620523.
8. Zhou DX, Liu YX, Xue YH Expression of CD44v6 and its association with prognosis in epithelial ovarian carcinomas [J]. Patholog Res Int, 2012, 2012: 908206.
9. Surowiak P, Materna V, Klak K., et al Prognostic value of immunohistochemical estimation of CD24 and Ki67 expression in cisplatin and paclitaxel treated ovarian carcinoma patients[J]. Pol J Pathol, 2005, 56(2): 69-74. (Pubitemid 41002455)
10. Surowiak P, Materna V, Kaplenko I, et al. Unfavorable prognostic value of CD24 expression in sections from primary and relapsed ovarian cancer tissue[J]. Int J Gynecol Cancer, 2006, 16(2): 515-521.